Literature DB >> 3678969

Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development?

R Löfberg1, B Tribukait, A Ost, O Broström, H Reichard.   

Abstract

During a prospective study lasting 3.5 years flow cytometric DNA analysis was evaluated as a possible predictor of dysplastic and malignant lesions in longstanding ulcerative colitis. Fifty three patients with total ulcerative colitis (mean disease duration of 22 years) were regularly colonoscoped. Biopsies of colonic mucosa were analysed by flow cytometric technique and were also assessed histologically. Findings of abnormal DNA pattern (aneuploidy) were compared with findings of dysplasia. Five patients (9%) had aneuploidy, four of those at repeated colonoscopies. Four of those patients also had various degrees of dysplasia. In one patient aneuploidy preceded the finding of dysplasia and in another aneuploidy preceded a well differentiated adenocarcinoma, grade Dukes' A subsequently found at surgery. Four additional patients had dysplasia, all in connection with macroscopic lesions, but were diploid. It is suggested that flow cytometric DNA analysis in long standing ulcerative colitis may be helpful in addition to histopathology in the detection of potential malignancy in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678969      PMCID: PMC1433223          DOI: 10.1136/gut.28.9.1100

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle.

Authors:  H Baisch; W Göhde; W A Linden
Journal:  Radiat Environ Biophys       Date:  1975-06-13       Impact factor: 1.925

2.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

Review 3.  The precarcinomatous phase of ulcerative colitis.

Authors:  R H Riddell
Journal:  Curr Top Pathol       Date:  1976

4.  Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study.

Authors:  B Tribukait; C Hammarberg; C Rubio
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1983-03

5.  Reversibility of bronchial cell atypia.

Authors:  G Auer; J Ono; M Nasiell; T Caspersson; H Kato; C Konaka; Y Hayata
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

6.  Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum.

Authors:  F T De Dombal; J M Watts; G Watkinson; J C Goligher
Journal:  Br Med J       Date:  1966-06-11

7.  Early detection of malignancy in ulcerative colitis. A flow-cytometric DNA study.

Authors:  C Hammarberg; P Slezak; B Tribukait
Journal:  Cancer       Date:  1984-01-15       Impact factor: 6.860

8.  Cancer risk in extensive ulcerative colitis.

Authors:  J Kewenter; H Ahlman; L Hultén
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

9.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

10.  Flow-cytometric DNA analysis as a means for early detection of malignancy in patients with chronic ulcerative colitis.

Authors:  C Hammarberg; C Rubio; P Slezak; B Tribukait; U Ohman
Journal:  Gut       Date:  1984-08       Impact factor: 23.059

View more
  12 in total

Review 1.  The value of mucin histochemistry, autoradiography and analysis of cellular DNA content for cancer surveillance in patients with ulcerative colitis.

Authors:  H Suzuki; K Matsumoto
Journal:  Jpn J Surg       Date:  1989-07

2.  DNA aneuploidy in Crohn's disease and ulcerative colitis: results of a comparative flow cytometric study.

Authors:  R Porschen; U Robin; A Schumacher; S Schauseil; F Borchard; K J Hengels; G Strohmeyer
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

3.  Comparative DNA analyses in longstanding ulcerative colitis with aneuploidy.

Authors:  R Löfberg; T Caspersson; B Tribukait; A Ost
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

4.  Microspectrophotometric DNA analysis in ulcerative colitis with special reference to its application in diagnosis of carcinoma and dysplasia.

Authors:  K Suzuki; T Muto; T Masaki; Y Morioka
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

5.  Combining aneuploidy and dysplasia for colitis' cancer risk assessment outperforms current surveillance efficiency: a meta-analysis.

Authors:  Rüdiger Meyer; Sandra Freitag-Wolf; Silke Blindow; Jürgen Büning; Jens K Habermann
Journal:  Int J Colorectal Dis       Date:  2016-10-20       Impact factor: 2.571

6.  Diagnostic value of DNA image cytometry in ulcerative colitis.

Authors:  R Keller; E C Foerster; A Köhler; B Floer; G Winde; H J Terpe; W Domschke
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

7.  Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancer.

Authors:  Sabine Tejpar; Robert D Odze
Journal:  Gastrointest Cancer Res       Date:  2009-09

8.  Carcinoma and DNA aneuploidy in Crohn's colitis--a histological and flow cytometric study.

Authors:  R Löfberg; O Broström; P Karlén; A Ost; B Tribukait
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

Review 9.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

10.  DNA aneuploidy in a case of rectosigmoid adenocarcinoma complicated by ulcerative colitis.

Authors:  K Makiyama; M Tokunaga; M Itsuno; W Zea-Iriarte; K Hara; T Nakagoe
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.